Bicycle Therapeutics Secures Long-Term 212Pb Supply Chain
CAMBRIDGE, England & BOSTON — December 16, 2025 — Bicycle Therapeutics plc, a clinical-stage pharmaceutical company pioneering bicyclic peptide–based...
Radiopharmaceuticals
Advertisement
Telix and Varian Launch Theranostics-EBRT Precision Oncology Collaboration
Melbourne, Australia & Palo Alto, CA – December 10, 2025 – Telix Pharmaceuticals Limited and Varian, a Siemens Healthineers...
Alpha-9 Oncology Appoints Paul Blanchfield as CEO to Drive Radiopharma Growth
BOSTON and VANCOUVER, BC, November 10, 2025 — Alpha-9 Oncology, Inc., a clinical-stage radiopharmaceutical company pioneering targeted cancer therapies,...
C-Ray Therapeutics Unveils Promising 225Ac-PSMA-CY313 Clinical Data at EANM 2025
BARCELONA, Spain, Oct. 8, 2025 — During the 2025 Annual Congress of the European Association of Nuclear Medicine (EANM...
Advertisement
